LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunityAkshay T. Krishnamurty, Shannon J. Turley, Justin A. Shyer et al.|Nature|2022Cited by 385
Ring-Closing Metathesis of Olefinic Peptides: Design, Synthesis, and Structural Characterization of Macrocyclic Helical PeptidesHelen E. Blackwell, Robert H. Grubbs, Jack Sadowsky et al.|The Journal of Organic Chemistry|2001Cited by 223
Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> ActivityThomas H. Pillow, Peter S. Dragovich, Amrita V. Kamath et al.|ChemMedChem|2019Cited by 193
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S. Dragovich, Xiaoyu Zhu, Thomas H. Pillow et al.|Journal of Medicinal Chemistry|2021Cited by 168